Palihapitiya Chamath's Form 4 filing
Prokidney Corp. (PROK) · filed Nov 14, 2023
- Accession no.
- 0001104659-23-118332
- Filed
- Nov 14, 2023, 9:15 PM ET
- Trade date
- Nov 9-14, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $897.9K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Palihapitiya ChamathCIK 0001715450 | 10% Owner |
| SC Master Holdings, LLCCIK 0001851024 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 9, 2023 | Class A ordinary shares | SSaleDisposed | −95,900 | $1.68F1 | −$160,699.63 | 6,416,967 | Indirect | |
| Nov 10, 2023 | Class A ordinary shares | SSaleDisposed | −85,900 | $1.61F3 | −$138,410.67 | 6,331,067 | Indirect | |
| Nov 13, 2023 | Class A ordinary shares | SSaleDisposed | −88,700 | $1.57F4 | −$139,675.89 | 6,242,367 | Indirect | |
| Nov 14, 2023 | Class A ordinary shares | SSaleDisposed | −306,200 | $1.50F5 | −$459,085.66 | 5,936,167 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.6250 to $1.7350. The reporting person undertakes to provide ProKidney Corp. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.5600 to $1.6900. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.5100 to $1.6200. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.3800 to $1.8500. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.